These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 18410977

  • 1. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
    Senft A, de Bree R, Hoekstra OS, Kuik DJ, Golding RP, Oyen WJ, Pruim J, van den Hoogen FJ, Roodenburg JL, Leemans CR.
    Radiother Oncol; 2008 May; 87(2):221-9. PubMed ID: 18410977
    [Abstract] [Full Text] [Related]

  • 2. Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
    Uyl-de Groot CA, Senft A, de Bree R, Leemans CR, Hoekstra OS.
    J Nucl Med; 2010 Feb; 51(2):176-82. PubMed ID: 20124045
    [Abstract] [Full Text] [Related]

  • 3. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
    Krabbe CA, Pruim J, van der Laan BF, Rödiger LA, Roodenburg JL.
    Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chest radiography or chest CT plus head and neck CT versus 18F-FDG PET/CT for detection of distant metastasis and synchronous cancer in patients with head and neck cancer.
    Kim Y, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
    [Abstract] [Full Text] [Related]

  • 6. Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
    Senft A, Hoekstra OS, Witte BI, Leemans CR, de Bree R.
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2643-50. PubMed ID: 26350882
    [Abstract] [Full Text] [Related]

  • 7. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
    Yi JS, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY, Roh JL.
    J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
    [Abstract] [Full Text] [Related]

  • 8. Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient?
    Brouwer J, de Bree R, Hoekstra OS, Golding RP, Langendijk JA, Castelijns JA, Leemans CR.
    Laryngoscope; 2005 Oct; 115(10):1813-7. PubMed ID: 16222201
    [Abstract] [Full Text] [Related]

  • 9. Interobserver variability in chest CT and whole body FDG-PET screening for distant metastases in head and neck cancer patients.
    Senft A, de Bree R, Golding RP, Comans EF, Van Waesberghe JH, Kuik JD, Hoekstra OS, Leemans CR.
    Mol Imaging Biol; 2011 Apr; 13(2):385-90. PubMed ID: 20533092
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical utility of 18F-FDG PET/CT for patients with recurrent head and neck squamous cell carcinoma.
    Ha SC, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY.
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [Abstract] [Full Text] [Related]

  • 12. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [Abstract] [Full Text] [Related]

  • 13. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM, Liao CT.
    J Clin Oncol; 2006 Sep 20; 24(27):4371-6. PubMed ID: 16983105
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A.
    Clin Otolaryngol; 2012 Jun 20; 37(3):197-206. PubMed ID: 22520870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients.
    Meeuwis J, Hoekstra OS, Witte BI, Boellaard R, Leemans CR, de Bree R.
    Oral Oncol; 2015 May 20; 51(5):536-40. PubMed ID: 25735655
    [Abstract] [Full Text] [Related]

  • 19. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
    Schwartz DL, Rajendran J, Yueh B, Coltrera M, Anzai Y, Krohn K, Eary J.
    Arch Otolaryngol Head Neck Surg; 2003 Nov 20; 129(11):1173-8. PubMed ID: 14623746
    [Abstract] [Full Text] [Related]

  • 20. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
    King AD, Ma BB, Yau YY, Zee B, Leung SF, Wong JK, Kam MK, Ahuja AT, Chan AT.
    Br J Radiol; 2008 Apr 20; 81(964):291-8. PubMed ID: 18344274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.